Showing results (741-750 of 772) with videos related to
Sort By:
Pageof 78
European Journal of Cancer (Oxford, England : 1990)|August 28, 2007
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicityM A de Korte, E G E de Vries, M N Lub-de Hooge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart FailureBryan P Schneider, Fei Shen, Laura Gardner, et al.Frontiers in Neurology|August 8, 2022
Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic EncephalopathyChristopher J Nowinski, Samantha C Bureau, Michael E Buckland, et al.Molecular Metabolism|September 23, 2016
Male-lineage transmission of an acquired metabolic phenotype induced by grand-paternal obesityJennifer E Cropley, Sally A Eaton, Alastair Aiken, et al.Elife|September 19, 2023
Atypical peripheral actin band formation via overactivation of RhoA and nonmuscle myosin II in mitofusin 2-deficient cellsYueyang Wang, Lee D Troughton, Fan Xu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialD Rayson, T M Suter, C Jackisch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01)Evandro de Azambuja, Marion J Procter, Dirk J van Veldhuisen, et al.Fertility and Sterility|November 11, 2003
Safety issues in cell-based intervention trialsLiza Dawson, Alison S Bateman-House, Dawn Mueller Agnew, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trialThomas M Suter, Marion Procter, Dirk J van Veldhuisen, et al.European Journal of Heart Failure|August 19, 2020
The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.Pageof 78